Anzeige
Mehr »
Login
Samstag, 18.01.2025 Börsentäglich über 12.000 News von 682 internationalen Medien
Letzte Chance, bevor die Bohrer dieses "Monster"-Vorkommen bei einem 13-Millionen-Unternehmen ansteuern
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
38 Leser
Artikel bewerten:
(0)

CNB Community Bancorp, Inc. Reports 2024 Results

Finanznachrichten News

HILLSDALE, Mich., Jan. 17, 2025 /PRNewswire/ -- CNB Community Bancorp, Inc. (OTCQX: CNBB), the parent company of County National Bank, today announced earnings for the three months and twelve months ended December 31, 2024. Earnings during the fourth quarter of 2024 totaled $2.4 million, a decrease of $72,000 from the $2.5 million earned during the three months ended December 31, 2023. Due to the previously reported buyback of shares completed in September of this year, the basic earnings per share increased to $1.20 during the three months ended December 31, 2024, up $0.03 from $1.17 during the fourth quarter of 2023. For the year ended December 31, 2024, CNB Community Bancorp, Inc. (the "Company") reported net income of $11.6 million, an increase of $971,000, or 9.1%, from the $10.6 million earned during the year ended December 31, 2023. Basic earnings per share increased to $5.42 during the year ended December 31, 2024, up $0.51 from $4.91 during 2023.

The annualized return on average assets (ROA) decreased to 0.78% for the three months ended December 31, 2024, down 5 basis points ("BPs") or 6.0% from 0.83% for the three months ended December 31, 2023. The annualized return on average equity (ROE) decreased to 9.87% for the current quarter, down from 10.63% for the fourth quarter of 2023. ROA increased to 0.93% from the 0.89% for the year ended December 31, 2023. ROE increased to 11.74% for 2024, up from 11.55% during the year ended December 31, 2023. Book value per share increased to $48.65 at December 31, 2024, up $4.74, or 10.8%, from $43.91 at December 31, 2023.

"The results from the strategic steps we took over this past year exceeded the return on equity & net interest margin that we expected for 2024," said Joseph R. Williams, President and CEO. "Furthermore, we continued to invest in talent and our banking teams generated a steady volume of attractive lending opportunities while maintaining our strong underwriting culture and overall credit quality."

"Our entire team has continued to focus on relationship banking, which includes bringing more of our existing Clients' deposit relationships into CNB while doing the same with new Clients," Williams added. "We have successfully utilized our model to move into new markets and we expect to continue to grow in those communities as well as within our existing footprint in the next year and beyond."

Financial Highlights

  • Total assets increased year-over-year $34.3 million, or 2.8%, to $1.28 billion.
  • Net loans increased $78.5 million, or 8.2%, to $1.03 billion at December 31, 2024 compared to $954.6 million at December 31, 2023.
  • Total deposits increased approximately $23.7 million, or 2.2%, to $1.10 billion at December 31, 2024.
  • Book value per share increased $4.74, or 10.8%, to $48.65 at December 31, 2024, up from $43.91 at December 31, 2023.
  • The Company completed a tender offer to repurchase 145,000 shares in the third quarter of 2024 paying its shareholders $38.50 per share. Total shares outstanding are 2,078,157 as of December 31, 2024.
  • Net income decreased $72,000, 2.9%, to $2.4 million for the three-month period ended December 31, 2024 but basic EPS increased $0.03, or 2.6%, to $1.20 from $1.17 in the fourth quarter of 2023.
  • Net interest income for the fourth quarter of 2024 increased $1.1 million to $11.4 million while for the twelve months ended December 31, 2024 net interest income increased $3.9 million or 9.6%.
  • Pre-tax, pre-provision income increased approximately $219,000 to $3.4 million in the fourth quarter of 2024, compared to $3.2 million in the fourth quarter of 2023. For 2024, pre-tax, pre-provision income was $15.4 million, compared to $13.8 million for 2023, and increase of 11.1%.

About CNB Community Bancorp Inc.
CNB Community Bancorp, Inc. (OTCQX:CNBB) is a one-bank holding company formed in 2005. Its subsidiary bank, County National Bank, is a nationally chartered full-service bank, which has served its local communities since its founding in 1934. CNB Community Bancorp, Inc. is headquartered in Hillsdale, Michigan and through its subsidiary bank offers banking products along with investment management and trust services to communities located throughout Southern Michigan.

Safe Harbor Statement
This news release and other releases and reports issued by the Company may contain "forward-looking statements." The Company cautions readers not to place undue reliance on any such forward-looking statements, which speak only as of the date made. The Company is including this statement for purposes of taking advantage of the safe-harbor provisions of the Private Securities Litigation Reform Act of 1995.

SOURCE CNB Community Bancorp, Inc.

© 2025 PR Newswire
Gewinner im Megamarkt
Biotechnologie ist eine der bedeutendsten Zukunftstechnologien unserer Zeit. Zahlreiche Biotechnologie- und Pharmakonzerne haben sich unter anderem dem Kampf gegen Tumorerkrankungen verschrieben. Der weltweite Markt für Krebsmedikamente verzeichnet ein stetiges Wachstum. Für das Jahr 2025 wird ein Umsatz von etwa 190,3 Milliarden Euro prognostiziert, mit einer erwarteten jährlichen Wachstumsrate von 6,42% bis 2029, was zu einem geschätzten Marktvolumen von 244,1 Milliarden Euro führen würde.

Wir haben 3 aussichtsreiche Biotechnologieaktien mit Schwerpunkt Erforschung und Entwicklung von Wirkstoffen gegen Tumorerkrankungen ausfindig gemacht, die in den kommenden Monaten und Jahren erhebliches Aufwärtspotenzial versprechen und Vervielfachungspotenzial besitzen.

Fordern Sie jetzt unseren neuen kostenlosen Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien durchstarten und zu Ihrem Börsenerfolg in 2025 beitragen könnten!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.